<DOC>
	<DOC>NCT00488670</DOC>
	<brief_summary>To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression.</brief_summary>
	<brief_title>Escitalopram and Depression in Elderly Alzheimer's Patients</brief_title>
	<detailed_description>This study will assess the efficacy, tolerability, and safety of escitalopram in the treatment of Major Depressive Disorder in patients with Alzheimer's disease over a 24-week period. It will also assess the efficacy and tolerability of escitalopram after 12 weeks of treatment.</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>&gt; 50 years Male &amp; female Alzheimer's disease Depressive episode</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Alzheimer's disease</keyword>
	<keyword>elderly</keyword>
	<keyword>open-label</keyword>
	<keyword>escitalopram</keyword>
</DOC>